Found: 15
Select item for more details and to access through your institution.
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 360, doi. 10.1007/s10637-018-0652-3
- By:
- Publication type:
- Article
Dynamic Evaluation of Circulating miRNA Profile in EGFR -Mutated NSCLC Patients Treated with EGFR-TKIs.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1520, doi. 10.3390/cells10061520
- By:
- Publication type:
- Article
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 2857, doi. 10.2147/DDDT.S124380
- By:
- Publication type:
- Article
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- case study
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study.
- Published in:
- Biomedical Reports, 2020, v. 12, n. 2, p. 59, doi. 10.3892/br.2019.1265
- By:
- Publication type:
- Article
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3707, doi. 10.1007/s00262-023-03522-3
- By:
- Publication type:
- Article
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5403, doi. 10.3390/cancers13215403
- By:
- Publication type:
- Article
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report.
- Published in:
- 2016
- By:
- Publication type:
- journal article